Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Apr 20 2016

Full Issue

Opioid Epidemic Casts Shadow On Marijuana Legalization In New England

Marijuana advocates have turned their attention to the fairly liberal enclave of northeastern states, but the region has been particularly hard hit by the opioid crisis making residents and lawmakers skittish on the topic. Meanwhile, Maine regulators are considering marijuana as an alternative to prescription pain killers, and a Minnesota senator is trying to increase access to naloxone, an anti-overdose drug.

The New York Times: Marijuana Legalization In New England Is Stalled By Opiate Crisis

First came Colorado and Washington. Then Alaska, Oregon and Washington, D.C. Now advocates for legal marijuana are looking to New England, hoping this part of the country will open a new front in their efforts to expand legalization nationwide. But this largely liberal region is struggling with the devastating effect of opiate abuse, which is disrupting families, taxing law enforcement agencies and taking lives. And many lawmakers and public officials are balking at the idea of legalizing a banned substance, citing potential social costs. (Bidgood, 4/19)

The Associated Press: Maine Could Be 1st State To OK Medical Pot To Treat Addicts

Maine could become the first state to add addiction to opioid prescriptions and illegal narcotics like heroin to its list of conditions that qualify for medical marijuana. Nearly 30 medical marijuana caregivers and patients told state regulators at a public hearing on Tuesday that marijuana eases the symptoms of opioid withdrawal and offers a healthier alternative to the prescription painkillers that can lead to addiction. (Bell, 4/19)

Minnesota Public Radio: MN Senator Proposing Bills To Make Anti-Overdose Drug More Available

A Minnesota lawmaker who lost a daughter to a heroin overdose is proposing funding to hand out the anti-overdose medication naloxone at treatment centers and needle exchanges across the state. (Collins and Wurzer, 4/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF